Further in-silico or functional analysis should be carried out to further investigate the effect of the identified SNP to ALCAM and RUNX1 gene as well as the crosstalk in between germline variations and somatic mutations in these breast cancer-associated genes. This evidence concerns the gene ALCAM and breast carcinoma.